Akt1/2 shRNA lentiviral particles (sc-37030-V) were provided by Santa Cruz Biotech and were added directly to primary NSCLC cells. After 24 h, puromycin (5.0 μg/ml) was added to select stable cells, where over 95% Akt1/2 protein knockdown efficiency was achieved.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.